Dr. Emiko Vogel

Oncology pharmacist · Charité Berlin · Germany (DE) · Oncology

Tier 3STK-0015GoodOwner MSL JWJames Whitfield

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: SCLC, NSCLC
Scientific interests: Brain metastasesirAE managementElderly patients
Engagement preference: Virtual
Advisory boards: 1
Publications: 9
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 3: 1 per year (assumption)

Last engaged: 15 Sept 2026 (today)
Next planned contact: 15 Sept 2027
Last 6 months vs target: 100%
2 of 1 expected engagements

Insights from this stakeholder (1)

INS-0082Elderly / ECOG 2 patients
01 Apr 2026 · Evidence gap
MediumClosed

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
15 Sept 2026	Scientific exchange	In person	James Whitfield	Vantrexa	Duration of responseComparator checkpoint monotherapy+1	0	—	Reviewed	ENG-0048
01 Apr 2026	Scientific exchange	Virtual	James Whitfield	Vantrexa	Elderly / ECOG 2 patients	1	—	Reviewed	ENG-0088

Timeline

15 Sept 2026
Scientific exchange
Duration of response, Comparator checkpoint monotherapy, Infusion-reaction management
01 Apr 2026
Scientific exchange
Elderly / ECOG 2 patients

Related stakeholders (2)

Charité Berlin

Prof. Benedikt Fischer
Academic nephrologist
Tier 1
Dr. Katarina Rossi
General neurologist
Tier 3